Quantum Biopharma (QNTM) Inventory Average (2025 - 2026)
Quantum Biopharma (QNTM) posted Inventory Average of $51800.5 for Q1 2026, down 20.16% sequentially from $64877.5 in Q4 2025, and down 50.92% YoY from $105549.0 in Q1 2025.
Quantum Biopharma (QNTM) Inventory Average (2025 - 2026) Analysis & Trends
Quantum Biopharma has reported Inventory Average for 2 years, with the latest figure at $51800.5 in Q1 2026.
- Quarterly Inventory Average fell 50.92% year-over-year to $51800.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51800.5 (down 50.92% YoY) and the FY2025 annual result came in at $84687.5, changed N/A from the prior year.
- Inventory Average fell to $51800.5 in Q1 2026 per QNTM's latest filing, from $64877.5 in the prior quarter.
- Over five years, Inventory Average peaked at $105549.0 in Q1 2025 and troughed at $51800.5 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Quantum Biopharma | 15.53 Mn | 11.89 Mn | - | 52,240.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52,240.00 |
| Mar 31, 2026 | 51,800.50 |
| Dec 31, 2025 | 64,877.50 |
| Sep 30, 2025 | 77,245.50 |
| Jun 30, 2025 | 85,362.50 |
| Mar 31, 2025 | 105,549.00 |